Latest Astellas Pharma US Inc. Stories
STAINES, England, April 11, 2011 /PRNewswire/ -- Astellas Pharma Europe Ltd.
TOKYO, March 22, 2011 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.(TSE:4503,"Astellas") ( http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition[1,2]. These data were presented for the first time this week at the...
TOKYO, Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that Donald B. Rice, PhD. will retire from Astellas Pharma Inc.'s affiliate Agensys, Inc. ("Agensys"). Sef Kurstjens, M.D., PhD.
CHICAGO and DEERFIELD, Ill., Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma US, Inc.
CHICAGO and DEERFIELD, Ill., Oct.
PHILADELPHIA, Sept. 25 /PRNewswire/ -- Today Astellas Pharma US, Inc.
PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones.
DEERFIELD, Ill., Sept. 17 /PRNewswire/ -- Today, approximately 500 employees at Astellas Pharma US, Inc.
DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- Astellas Pharma US, Inc.
DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- On January 1, 2011, the Donate Life float will roll through the streets of Pasadena reminding millions of viewers of the Rose ParadeÂ® to "Seize the Day" and register as organ donors in an effort to save lives.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.